BMRN
USDBioMarin Pharmaceutical Inc. Common Stock
Echtzeitkurs
Kursdiagramm
Schlüsselkennzahlen
Marktkennzahlen
Eröffnung
$52.560
Hoch
$52.760
Tief
$51.800
Volumen
2.96M
Unternehmensfundamentaldaten
Marktkapitalisierung
10.1B
Branche
Biotechnologie
Land
United States
Handelsstatistiken
Durchschnittliches Volumen
2.34M
Börse
NMS
Währung
USD
52-Wochen-Spanne
Ähnliche Nachrichten
Bernstein Maintains Outperform on BioMarin Pharmaceutical, Lowers Price Target to $88
Bernstein analyst William Pickering maintains BioMarin Pharmaceutical with a Outperform and lowers the price target from $95 to $88.
Truist Securities Maintains Buy on BioMarin Pharmaceutical, Lowers Price Target to $80
Truist Securities analyst Joon Lee maintains BioMarin Pharmaceutical with a Buy and lowers the price target from $90 to $80.
Wells Fargo Maintains Overweight on BioMarin Pharmaceutical, Lowers Price Target to $70
Wells Fargo analyst Mohit Bansal maintains BioMarin Pharmaceutical with a Overweight and lowers the price target from $90 to $70.
Barclays Maintains Overweight on BioMarin Pharmaceutical, Lowers Price Target to $80
Barclays analyst Gena Wang maintains BioMarin Pharmaceutical with a Overweight and lowers the price target from $86 to $80.
HC Wainwright & Co. Maintains Neutral on BioMarin Pharmaceutical, Lowers Price Target to $55
HC Wainwright & Co. analyst Mitchell S. Kapoor maintains BioMarin Pharmaceutical with a Neutral and lowers the price target from $60 to $55.
Morgan Stanley Maintains Overweight on BioMarin Pharmaceutical, Lowers Price Target to $98
Morgan Stanley analyst Matthew Harrison maintains BioMarin Pharmaceutical with a Overweight and lowers the price target from $104 to $98.
BioMarin Reports Third Quarter 2025 Results and Provides Corporate Update
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced financial results for the third quarter ended September 30, 2025. "We are pleased with...
Ähnliche Aktien
Bleiben Sie auf dem Laufenden
Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.